Ovation iX Iliac Stent Graft Iliac Limb (REF TV-IL1410120-J)Recalls & reported problems
Endologix LLC · The TriVascular® Ovation Prime® Abdominal Stent Graft System with the Ovation iX Iliac Stent Graft is an endovascular device delivered via a small diameter catheter to treat abdominal aortic aneurysms (AAAs). The stent graft is designed to reline the diseased vasculature, providing an endovascular blood conduit for isolating the aneurysm from the high pressure flow of blood, thereby reducing the risk of rupture. The stent graft is a modular configuration comprised of an aortic body section, iliac limbs, and iliac extensions as required. The TriVascular Ovation Prime Abdominal Stent Graft System with the Ovation iX Iliac Stent Graft includes, an Aortic Body Stent Graft and delivery catheter, Iliac Limb Stent Grafts and delivery catheters, Iliac Extension Stent Grafts and delivery catheters, as required, a Fill Polymer Kit, and an Autoinjector. · Class 3 · Implant
All models of Ovation iX Iliac Stent Graft (66)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI M701TVIL1410120J1), received between Oct 12, 2018 and Jan 31, 2020 — classified as 2 injuries.
The most frequently reported specific device problem is “Deformation Due to Compressive Stress” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Deformation Due to Compressive Stress1
- Detachment of Device or Device Component1
- Insufficient Device Problem Information1
- Patient-Device Incompatibility1
- Physical Resistance/Sticking1
Patient problems
- Failure of Implant1
- Perforation1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryJan 31, 2020Patient-Device Incompatibility; Insufficient Device Problem Information; Patient-Device Incompatibility; Insufficient Device Problem Information
THE PATIENT WAS INITIALLY TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) WITH THE OVATION IX ABDOMINAL AORTIC ANEURYSM STENT. APPROXIMATELY THREE (3) YEARS POST INITIAL PROCEDURE, THE PATIENT PRESENTED WITH A LEAK IN THE LIMB AREA (CLASSIFIED AS A TYPE IB ENDOLEAK) AS DETECTED BY CT (COMPUTED TOMOGRAPHY) SCAN. THE PHYSICIAN ELECTED TO TREAT THE PATIENT BY IMPLANTING AN OVATION IX ILIAC LIMB ON (B)(6) 2020. AS OF DATE, THERE HAVE BEEN NO ADDITIONAL PATIENT SEQUELAE REPORTED. ADDITIONAL INFORMATION: NOTE: THIS PATIENT HAD A PREVIOUS REPORTED EVENT UNDER 3008011247-2018-00081 FOR A TYPE 1A AND 2 ENDOLEAKS THAT WAS TREATED WITH PALMAZ (NON- ENDOLOGIX) BARE METAL STENT AND AN OVATION IX EXTENDER. DURING THE CLINICIAN ASSESSMENT, A PERSISTENT TYPE 1A ENDOLEAK AND TYPE 2 ENDOLEAK (NON - DEVICE FAILURE) FROM THE LUMBAR ARTERY WERE IDENTIFIED. THE FINAL PATIENT STATUS WAS REPORTED TO BE STABLE.
Patient problems: Failure of Implant
MAUDE report 9654119 ↗InjuryOct 12, 2018Deformation Due to Compressive Stress; Detachment of Device or Device Component; Physical Resistance/Sticking; Deformation Due to Compressive Stress; Detachment of Device or Device Component; Physical Resistance/Sticking
AN OVATION IX ABDOMINAL STENT GRAFT SYSTEM WAS IMPLANTED TO TREAT AN ABDOMINAL AORTIC ANEURYSM. DURING THE SECONDARY PROCEDURE FOR TREATMENT OF AN ENDOLEAK, THERE WAS AN ISSUE WITH THE RE-LINE AND THE LEFT ILIAC LIMB WAS TRAPPED BY A STRUT AND THE INNER CORE AND NOSECONE WOULD NOT COME OUT THROUGH THE 17FR SHEATH. THE PHYSICIAN PULLED EXTREMELY HARD AND THE NOSECONE DETACHED FROM THE SYSTEM. AFTER SOME MANIPULATING THE PHYSICIAN WAS ABLE TO GET THE SYSTEM OUT. THE SEPARATED NOSECONE WAS RETRIEVED FROM THE PATIENT BODY. ADDITIONALLY, DUE TO THE PHYSICAL RESISTANCE UPON REMOVAL OF THE OVATION IX ILIAC LIMB SYSTEM, THE LEFT ILIAC WAS PERFORATED. THE PERFORATION WAS TREATED WITH PLACEMENT OF A NON-ENDOLOGIX COVERED STENT. AN OVATION IX ILIAC LIMB WAS SUCCESSFULLY DEPLOYED. THE PATIENT WAS STABLE. NO ADDITIONAL EVENT OR PATIENT INFORMATION IS AVAILABLE.
Patient problems: Perforation
MAUDE report 7959780 ↗
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page